Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
Eton Pharmaceuticals (Nasdaq: ETON) said members of its executive leadership will host 1x1 meetings at the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025 in New York, NY.
Investors or institutional representatives seeking a meeting are instructed to contact their Craig-Hallum institutional sales representative to schedule a 1x1.
Eton Pharmaceuticals (Nasdaq: ETON) ha dichiarato che i membri della direzione esecutiva ospiteranno incontri 1x1 presso la sedicesima Conferenza Annuale Craig-Hallum Alpha Select il 18 novembre 2025 a New York, NY.
Investitori o rappresentanti istituzionali interessati a un incontro sono invitati a contattare il loro rappresentante delle vendite istituzionali Craig-Hallum per fissare un 1x1.
Eton Pharmaceuticals (Nasdaq: ETON) afirmó que los miembros de su liderazgo ejecutivo organizarán reuniones 1x1 en la 16th Annual Craig-Hallum Alpha Select Conference el 18 de noviembre de 2025 en Nueva York, NY.
Los inversores o representantes institucionales que deseen una reunión deben ponerse en contacto con su representante de ventas institucionales de Craig-Hallum para programar una 1x1.
Eton Pharmaceuticals (Nasdaq: ETON)의 경영진 구성원들이 1대1 미팅을 제16회 Craig-Hallum Alpha Select Conference에서 2025년 11월 18일 뉴욕 시에서 주최한다고 밝혔습니다.
회의를 원하는 투자자나 기관 대표는 Craig-Hallum 기관 영업 담당자에게 연락해 1대1 일정을 잡으라고 안내받았습니다.
Eton Pharmaceuticals (Nasdaq: ETON) a déclaré que les membres de sa direction exécutive organiseront des réunions en tête-à-tête lors de la 16e Conférence Annuelle Craig-Hallum Alpha Select le 18 novembre 2025 à New York, NY.
Les investisseurs ou représentants institutionnels souhaitant une rencontre sont priés de contacter leur représentant commercial institutionnel de Craig-Hallum pour planifier une 1x1.
Eton Pharmaceuticals (Nasdaq: ETON) gab bekannt, dass Mitglieder der Geschäftsführung 1-zu-1-Gespräche während der 16th Annual Craig-Hallum Alpha Select Conference am 18. November 2025 in New York, NY durchführen werden.
Investoren oder institutionelle Vertreter, die ein Treffen wünschen, werden gebeten, ihren Craig-Hallum Institutional Sales Representative zu kontaktieren, um einen 1x1-Termin zu vereinbaren.
Eton Pharmaceuticals (Nasdaq: ETON) ذكرت أن أعضاء قيادتها التنفيذية سيستضيفون اجتماعات 1x1 في المؤتمر السنوي السادس عشر Alpha Select Craig-Hallum في 18 نوفمبر 2025 في نيويورك، نيويورك.
يُطلب من المستثمرين أو الممثلين المؤسسيين الراغبين في اجتماع الاتصال بـممثل المبيعات المؤسسية Craig-Hallum لديهم لترتيب اجتماع 1x1.
- None.
- None.
DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host 1x1 meetings at the 16th Annual Craig-Hallum Alpha Select Conference being held November 18, 2025 in New York, NY.
To schedule a 1x1 meeting with the Company, please contact your Craig-Hallum institutional sales representative.
About Eton Pharmaceuticals
Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eight commercial rare disease products: KHINDIVI™, INCRELEX®, ALKINDI SPRINKLE®, GALZIN®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has five additional product candidates in late-stage development: ET-600, Amglidia®, ET-700, ET-800 and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: Eton Pharmaceuticals.